AZD1222-induced mucosal immune responses are influenced by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection. Aksyuk et al.

Published: 6 December 2022| Version 1 | DOI: 10.17632/3nxrpnf7m3.1
Contributors:
,
,
,
,
,
,
,
,
,
,

Description

Supplemental Table 3. Summary of GMTs, GMFRs, and seroresponse rates of anti-SARS-CoV-2 spike IgG and IgA as measured by MSD serology assay. Related to Figures 1–2.

Files

Categories

Vaccination, COVID-19

Funding

US Government

W15QKN-20-9-1003

Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority

W15QKN-21-9-1003

Infectious Diseases Clinical Research Consortium through the National Institute of Allergy and Infectious Diseases,

UM1 AI 148684, UM1 AI 148450, UM1 AI 148372, and UM1 AI 148574

License